The Effect of Golden Sea cucumber (Stichopus hermanii) and Hyperbaric Oxygen Therapy to The Expression of Osteoprotegerin in Diabetes Mellitus Induce by Porphyromonas gingivalis Bacteria

Authors

  • Luthvina Setiami Aziza Undergraduate Faculty of Dentistry Hang Tuah University Surabaya
  • Kristanti Parisihni Biologi oral Fakultas Kedokteran Gigi Universitas Hang Tuah
  • Dian Mulawarmanti Biologi oral Fakultas Kedokteran Gigi Universitas Hang Tuah

Keywords:

Diabetes Melitus, Periodontitis, Alveolar Bone Resorption, Osteoprotegerin, Immunohistochemical, Stichopus hermanii, hyperbaric Oxygen .

Abstract

Background: Diabetes mellitus (DM) with Periodontitis cause severe  alveolar bone resorption. Osteoprotegerin prevent osteoclastogenesis process so that inhibited alveolar bone resorption. Stichopus hermanii powder and hyperbaric oxygen therapy (HBO) have  content  and good effects in wound healing. Purpose: The aim of this reseach was to analyze the effect of Stichopus hermanii powder and HBO therapy  in  the increasing of osteoprotegerin expression on DM with periodontitis. Materials and Methods: The research was an experimental laboratories post test only control group design.  Twenty  Wistar rats were divided into 5 groups. K0 was negative group while  K1 was positive group K1-K4 groups were induced with 65mm/kg STZ single dose and 2ml bacterium P. gingivalis., K2 was treated with 3%golden sea cucumber powder in gel form. K3 was treated with OHB therapy 2.4 ATA for 7 days and K4 given a combination of both. Osteoprotegrin expression on osteoblast of alveolar mandible bone were examined by immunohistochemical staining. Data were analyzed by Kruskal-Wallis and Mann-Whitney test. Result: Kruskal-Wallis result showed significant differences from each treatment group (p <0.05). Mann-Whitney test showed the decreasion in the expression of osteoprotegerin between K1(2:50 ± 0.577) compare with K0 (p<0.05). Golden sea cucumber powder, HBO therapy and both combination had  increased osteoprotegerin expression.significancy in K2(8.25 ± 1.258), K3 (5.75 ± 0.957) and K4(12.50 ± 2.082) (p<0,05). Conclusion: Stichopus hermanii powder 3% and 2.4 ATA OHB therapy for 7 days increased  the expression osteoprotegrin on DM with periodontitis.

Downloads

Download data is not yet available.

References

Nandya, Erna Manduratna dan Agustina EF. Status Kesehatan Jaringan Periodontal Pada Pasien Diabetes Mellitus Tipe 2 Dibandingkan Dengan Pasien Non Diabetes Mellitus Berdasarkan GPI; 2011. P.2 Available at http://journal.unair.ac.id/filerPDF/e-Journal%20Status%20kesehatan%20jaringan%20periodontal.pdf.

Zhang W, Ju J, Rigney T, Tribble G. Porphyromonas gingivalis Infection Increases Osteoclastic Bone Resorption and Osteoblastic Bone Formation in a Periodontitis Mouse Model. BMC Oral Health 2014; 14(89): 9-1.

Lely SMA, Indirawati T. Pengaruh Kadar Glukosa Darah Terkontrol Terhadap Penurunan Derajat Kegoyangan Gigi Penderita Diabetes Melitus di RS Persahabatan Jakarta. Media Litbang Jakarta 2004; 14(3): 44-37.

Pacios S, Andriankaja O, Kang J, Alnammary M, Bae J, Bazerra BB, Scheiner H, Fine DH, Graves DT. Bacterial Infection Increases Periodontal Bone Loss in Diabetic Rats Through Enhanced Apoptosis. The American Journal of Pathology 2013; 183(6): 1935-1929.

Maeley BL & Oates TW. Diabetes Mellitus and Periodontal Disease. Department of Peridontics University of Texas Health Science Center. J Periodontol 2006; 8: 1289-303.

Kesic L, Milasin J, Igic M and Obradovic R. Microbial Etiology of Periodontal Disease–Mini Review. Medicine and Biology 2008; 15(1): 6-1.

Graves D. 2008. Cytokines that Promote Periodontal Tissue Destruction. Journals of Periodontology, 79(8): 1591-1585.

Anil S, Varma V, Preethanath RS, Anand & Al Farraj A. 2012. The Emerging Concepts on The Impact of Periodontitis on Systemic Health. Periodontal Disease-A Clinician’s Guide; 2012. P. 149 Available from: http://www.intechopen.com/download/pdf/27460.

Schulze A & Busse M. Periodontal Disease in Diabetics : Relationship, Prevention, and Treatment. General Outpatient Ambulance and Dental Ambulance of the Institute of Sportsmedicine, University of Leipzig. CSMI 2008; 1(2): 4-1.

Morran MP, Alexander LA, Slotterbeck BD, Mclnerney MF. Dysfunctional Innate I Immune Responsiveness to Porphyromonas Gingivalis Lipopolysaccharide in Diabetes. Oral Microbiology Immunology 2009; 24: 339-331.

Signoretto C, Bianchi F, Bianchi F, Burlacchini, Canepari P. Microbiological Evaluation of The Effects of Hyperbaric Oxygen Periodontal Disease. Dipartimento di Patologia, Sezione di Microbiologia Universita di Verona Italia. New Microbiol 2007; 30(4): 437-431.

Ratnawati A, Izak DR, Supardi A. Sintesis dan Karakterisasi Kolagen dari Teripang-Kitosan sebagai Aplikasi Pembalut Luka; 2011. P. 5. Available at http://journal.unair.ac.id/filerPDF/jurnal%20AyuRatnawati.pdf.

Bordbar S, Anwar F, Saari N. High-Value Components and Bioactives from Sea Cucumbers for Functional Foods-A Review. Marine Drgs 2011; 9: 1805-761.

Tat SK, Pelletier JP, Verges J, Lajeunesse D, Montelle E, Fahmi H, Lavigne M, Pelletier JM. Chondroitin and Glucosamine Sulfate in Combination Decrease the Pro-Resorptive Properties of Human Osteoarthritis Subchondral Bone Osteoblasts: A Basic Science Study. Arthritis Research & Therapy 2007; 9(6): 10-1.

Muttaqien W. Daya Hambat Teripang emas (stichopus hermanii) Terhadap Pertumbuhan Bakteri Mixed Periodontal. Fakultas Kedokteran Gigi Universitas Hang Tuah Surabaya. Indonesia; 2011. Hlm. 25-24.

Bhutani S and Vishwanath G. Hyperbaric Oxygen and Wound Healing. Indian Journal of Plastic Surgary 2012; 45(2): 324-316.

Jain N, Deepa D. Applications of Hyperbaric Oxygen Therapy in Dentistry: A Mini Review. Journals of Interdiciplinary Dentistry 2014; 4: 32-27.

Al Hadi H, Smerdon GR, Fox SW. Hyperbaric Oxygen Therapy Suppresses Osteoclast Formation and Bone Resorption. Journals of Orthopedi Research 2013; 1844-1839.

Cochran, DL. Inflammation and Bone Loss in Periodontal Disease. Journals of Periodontal Online 2008; 79(8): 1576-1569.

Kearns AE, Kholas S, Kostenuik PJ. Receptor Activator of Nuclear Factor B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease. Endocrine Reviews 2008; 29(2): 192-155.

Koide M, Kobayashi Y, Ninomiya T, Nakamura M, Yasuda H, Arai Y, Okahashi N, Yoshinari N, Takahashi N, Udagawa N. Osteoprotegerin-Deficient Male Mice as a Model for Severe Alveolar Bone Loss: Comparison With RANKLOverexpressing Transgenic Male Mice. Endocrinology 2013; 154(2): 782-773.

Hienz SA, Paliwal S, Ivanoski S. Mechanisms of Bone Resorption in Periodontitis. Journals Immunology Research.; 2014. P. 10-1.

Mulawarmanti D & Widyastuti. Effect of Hyperbaric Oxygen Therapy on Malondialdehyde Levels in Saliva of Periodontitis Patients with Type 2 Diabetes Mellitus. Dental Journal Majalah Kedokteran Gigi 2008; 41(4): 39-30.

Srinivasan K , Ramarao P. 2007. Animal Models in Type 2 Diabetes Research: An Overview. Indiana Journals Medical Research 2007; 125: 472-451.

Kesavalu L, Sathishkumar S, Bakthavatchalu V, Matthews C, Dawson D, Steffen M, Ebersole JL. Rat Model of Polymicrobial Infection, Immunity, and Alveolar Bone Resorption in Periodontal Disease. Infection and Immunity 2007; 75(4): 1712-1704.

Praptiwi. 2008. Inokulasi Bakteri dan Pemasangan Cincin Ligatur untuk Induksi Periodontitis pada Tikus. Majalah Kedokteran Gigi 2008; 15(1): 84-81.

Prabowo S, Nataatmadja M, Hadi JP, Dikman I, Handajani F, Tehupuring SEJ, Soetarso I, Suryokusumo MG, Aulanni’am A, Herawati A, West M. Hyperbaric Oxygen Treatment in a Diabetic Rat Model is Associated with a Decrease in Blood Glukose, Regression of Organ Demage and Improvement in Wound Healing. Scientific Research Health 2014; 6: 1958-1950.

Sharp T, Saunder G. Methode of Euthanasia; 2004. P. 5. Available at http://www.shellharbour.nsw.gov.au./filedata/pdf/methodeofeuthanasia.pdf.

Yulvie W. Evaluasi Ekspresi RANKL Dan OPG Pada Ameloblastoma Tipe Folikular, Tipe Fleksiform, Dan Tipe Campuran. Tesis Fakultas Kedokteran Gigi Program Studi Bedah Mulut Dan Maksilofasial; 2012. Hlm. 22-1.

Claudino M, Gennaro G, Cestari TM, Spadella CT, Garlet GP, Assis GF. Spontaneous Periodontitis Development in Diabetic Rats Involves an Unrestricted Expression of Inflammatory Cytokines and Tissue Destructive Factors in the Absence of Major Changes in Commensal Oral Microbiota. Experimental Diabetes Research; 2012. P. 10-1.

Malik G, Lehl G, Talwar M. Association Of Periodontitis With Diabetes Mellitus: A Review. Journal of Medical 2011; 1(1): 14-10.

Nugroho AE. Review Hewan Percobaan Diabetes Mellitus : Patologi dan Mekanisme Aksi Diabetogenik. Laboratorium Farmakologi dan Toksikologi, Fakultas Farmasi Universitas Gadjah Mada. Biodiversitas 2006; 7(4): 382-378.

Golz L, Memmert S, Rath-Deschner B, Joger A, Appel T, Baumgarten G, Gotz W, Frede S. LPS from P. gingivalis and Hypoxia Increases Oxidative Stress in Periodontal Ligament Fibroblasts and Contributes to Periodontitis. Research Artikel Hindawi; 2014. P. 13-1.

Preshaw PM, Alba L, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K, Taylor R. Periodontitis and Diabetes : a Two-Way Relationship. Diabetologi 2012; 55(1): 31-21.

Bahrami Y, Zhang W, Chataway T, and Franco C. Structural Elucidation of Novel Saponins in the Sea Cucumber Holothuria lesson. Mar. Drugs 2014; 12(8): 4473-4439.

Nair MP, Mahajan S, Reynolds JL, Aalinkel R, Nair H, Schwartz SA and Kandaswami C. The Flavonoid Quercetin Inhibits Proinflammatory Cytokine (Tumor Necrosis Factor Alpha) Gene Expression in Normal Peripheral Blood Mononuclear Cells via Modulation of the NF-kB System. Clinical and Vaccine Immunology 2006; 13(3): 321-319.

Trzeciakiewicz A, Habauzit V and Hurcajada MN. When Nutrition Interacts with Osteoblast Function: Molekuler Mechanism of Polyphenols. Nutrition Research Review 2009; 22: 77.

Kveiborg M, Flyvbjerg A, Eriksen EF, Kassem M. Transforming Growth Factor-1 Stimulates the Production of Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 in Human Bone Marrow Stromal Osteoblast Progenitors. Journal of Endocrinology 2001; 169: 549-61.

Thomas GP, Baker SUK, Eisman JA, Gardiner EM. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. Journals of Endocrinology 2001; 170: 460-451.

Lovu M, Dumais G and Du Souich P. Anti-inflammatory activity of chondroitin sulfate. International. Cartilage Repair Society 2008; 16: 18-14.

Harnanik T. Efek Oksigenasi Hiperbarik Terhadap Peningkatan Aktivitas Antioksidan pada Penderita Diabetes Mellitus Tipe 2. Tesis. Surabaya: Program Pasca Sarjana. Universitas Airlangga; 2008. Hlm. 89-87.

Thom SR. Oxidative Stress in Fundamental to Hyperbaric Oxygen Therapy. J Appl Physiol 2009; 106: 995-988.

Huda N. Pengaruh Hiperbarik Oksigen Teradap Perfusi Perifer Luka Gangren pada Penderita DM di RSAL Dr.Ramelan Surabaya. Tesis. Fakultas Ilmu keperawatan Universitas Indonesia; 2010. Hlm. 106-103.

Al Hadi HW. The effect of Hyperbaric Oxygen Therapy on Osteoclast and Osteoblast Function. Thesis Faculty of Science and Technology; 2013. P. 130-13.

Downloads

Published

2021-09-14

How to Cite

Luthvina Setiami Aziza, Kristanti Parisihni, & Dian Mulawarmanti. (2021). The Effect of Golden Sea cucumber (Stichopus hermanii) and Hyperbaric Oxygen Therapy to The Expression of Osteoprotegerin in Diabetes Mellitus Induce by Porphyromonas gingivalis Bacteria. DENTA JURNAL KEDOKTERAN GIGI, 10(2), 165–174. Retrieved from https://journal-denta.hangtuah.ac.id/index.php/jurnal/article/view/138

Issue

Vol. 10 No. 2 (2016): Agustus

Section

Articles

License

Copyright (c) 2016 Universitas Hang Tuah

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-ShareAlike 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 – Definitions.

  1. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.
  2. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.
  3. BY-SA Compatible License means a license listed at creativecommons.org/compatiblelicenses, approved by Creative Commons as essentially the equivalent of this Public License.
  4. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.
  5. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.
  6. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.
  7. License Elements means the license attributes listed in the name of a Creative Commons Public License. The License Elements of this Public License are Attribution and ShareAlike.
  8. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.
  9. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.
  10. Licensor means the individual(s) or entity(ies) granting rights under this Public License.
  11. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.
  12. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.
  13. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 – Scope.

  1. License grant.
    1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:
      1. reproduce and Share the Licensed Material, in whole or in part; and
      2. produce, reproduce, and Share Adapted Material.
    2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.
    3. Term. The term of this Public License is specified in Section 6(a).
    4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)(4) never produces Adapted Material.
    5. Downstream recipients.
      1. Offer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.
      2. Additional offer from the Licensor – Adapted Material. Every recipient of Adapted Material from You automatically receives an offer from the Licensor to exercise the Licensed Rights in the Adapted Material under the conditions of the Adapter’s License You apply.
      3. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.
    6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

  2. Other rights.

    1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.
    2. Patent and trademark rights are not licensed under this Public License.
    3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.

Section 3 – License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

  1. Attribution.

    1. If You Share the Licensed Material (including in modified form), You must:

      1. retain the following if it is supplied by the Licensor with the Licensed Material:
        1. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);
        2. a copyright notice;
        3. a notice that refers to this Public License;
        4. a notice that refers to the disclaimer of warranties;
        5. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;
      2. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and
      3. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.
    2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.
    3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.
  2. ShareAlike.

    In addition to the conditions in Section 3(a), if You Share Adapted Material You produce, the following conditions also apply.

    1. The Adapter’s License You apply must be a Creative Commons license with the same License Elements, this version or later, or a BY-SA Compatible License.
    2. You must include the text of, or the URI or hyperlink to, the Adapter's License You apply. You may satisfy this condition in any reasonable manner based on the medium, means, and context in which You Share Adapted Material.
    3. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, Adapted Material that restrict exercise of the rights granted under the Adapter's License You apply.

Section 4 – Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

  1. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database;
  2. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material, including for purposes of Section 3(b); and
  3. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 – Disclaimer of Warranties and Limitation of Liability.

  1. Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You.
  2. To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You.
  1. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 – Term and Termination.

  1. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

  2. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

    1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or
    2. upon express reinstatement by the Licensor.
    For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.
  3. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.
  4. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 – Other Terms and Conditions.

  1. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.
  2. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 – Interpretation.

  1. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.
  2. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.
  3. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.
  4. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.

Most read articles by the same author(s)